ReleaseWire Connect

An investigation on behalf of investors of RealPage, Inc. (NASDAQ:RP) shares over potential securities laws violations by RealPage and certain of its directors and officers in connection certain financial statements was announced.

An investor, who currently holds shares of Measurement Specialties, Inc. (NASDAQ:MEAS) filed a lawsuit in effort to halt the proposed takeover of Measurement Specialties, Inc. by TE Connectivity Ltd at $86 per share.

An investigation on behalf of investors of Adobe Systems Incorporated (NASDAQ:ADBE) shares over potential securities laws violations by Adobe Systems and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors, who currently hold shares of International Game Technology (NYSE:IGT) shares, was announced concerning whether the takeover of International Game Technology by GTECH S.p.A for a value of $18.25 per share is unfair to NYSE:IGT stockholders.

An investor, who currently holds shares of Vitacost.com, Inc. (NASDAQ:VITC) filed a lawsuit in effort to halt the proposed takeover of Vitacost.com, Inc. by The Kroger Co for $8.00 per share.

An investor, who currently holds shares of Covidien plc (NYSE:COV) filed a lawsuit in effort to halt the proposed takeover of Covidien plc by Medtronic at a value of $93.22 per share.

An investigation on behalf of investors in shares of Lumber Liquidators Holdings Inc (NYSE:LL) was announced concerning whether certain Lumber Liquidators officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investor, who currently holds shares of MICROS Systems, Inc. (NASDAQ:MCRS) filed a lawsuit in effort to halt the proposed takeover of MICROS Systems, Inc. by Oracle for $68.00 per share.

An investigation on behalf of current long-term investors in shares of Accretive Health, Inc. (OTCMKTS:ACHI) shares was announced concerning possible breaches of fiduciary duties by the Company or its fiduciaries.

An investigation on behalf of investors, who currently hold shares of Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) shares, was announced concerning whether the takeover of Salix Pharmaceuticals, Ltd. by Cosmo Pharmaceuticals S.p.A is unfair to NASDAQ:SLXP stockholders.